Literature DB >> 10826545

Effect of verapamil on lenticular calcium, magnesium and iron in radiation exposed rats.

Y Bardak1, O Cekiç, Y Totan, M Cengiz.   

Abstract

PURPOSE: To investigate the effect of verapamil on lenticular calcium, magnesium, iron and on radiation-induced cataract in rats.
METHODS: Thirty-seven, female, Wistar Albino rats, weighing 180-230 g were randomly grouped as follows: control group (10 rats), radiation group (13 rats) and radiation-verapamil group (14 rats). Both radiation and radiation-verapamil groups received 5 Gy radiation to the whole body in a single dose, including both eyes within the irradiation volume; in addition the verapamil group received daily subcutaneous injections of 8 mg/kg verapamil starting on the first day of radiation. At the end of an 8-week experimental period, the animals were killed by decapitation. Lenticular calcium, magnesium, and iron levels were studied.
RESULTS: The mean lens calcium level for the radiation group was significantly higher than that for the control and radiation-verapamil groups and, there was no significant difference between the control and radiation-verapamil groups. The mean lens magnesium value for the radiation group was significantly higher than that for the control group. In the radiation-verapamil group the mean lens magnesium content was significantly lower than that for the radiation group. The iron level in the radiation group was significantly higher than that for the radiation-verapamil group.
CONCLUSIONS: The lens calcium, magnesium and iron contents increased after radiation exposure. Verapamil treatment significantly reduced the increase in the lenticular content of calcium, magnesium and iron, indicating a probable protective effect of verapamil in radiation-induced cataract formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10826545     DOI: 10.1023/a:1006335826463

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  23 in total

1.  Lens epithelium and radiation cataract. I. Preliminary studies.

Authors:  B V Worgul; G R Merriam; A Szechter; D Srinivasan
Journal:  Arch Ophthalmol       Date:  1976-06

2.  Regional distribution of calcium in alloxan diabetic rabbit lens.

Authors:  K R Hightower; M V Riley; J McCready
Journal:  Curr Eye Res       Date:  1989-05       Impact factor: 2.424

Review 3.  Mechanisms initiating cataract formation. Proctor Lecture.

Authors:  J H Kinoshita
Journal:  Invest Ophthalmol       Date:  1974-10

4.  Nifedipine for radiation oesophagitis.

Authors:  E Finkelstein
Journal:  Lancet       Date:  1986-05-24       Impact factor: 79.321

5.  Development and reversal of calcium-induced opacities in vitro.

Authors:  K R Hightower; M Dering
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-09       Impact factor: 4.799

6.  Calcium content and distribution in human cataract.

Authors:  K R Hightower; V N Reddy
Journal:  Exp Eye Res       Date:  1982-03       Impact factor: 3.467

7.  ATP hydrolysis kinetics of Na,K-ATPase in cataract.

Authors:  M H Garner; A Spector
Journal:  Exp Eye Res       Date:  1986-04       Impact factor: 3.467

8.  Oxidative inhibition of Ca2+-ATPase in the rabbit lens.

Authors:  D Borchman; C A Paterson; N A Delamere
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-07       Impact factor: 4.799

9.  Lenticular calcium, magnesium, and iron levels in diabetic rats and verapamil effect.

Authors:  O Cekic; Y Bardak
Journal:  Ophthalmic Res       Date:  1998       Impact factor: 2.892

10.  Calcium antagonists protect mice against lethal doses of ionizing radiation.

Authors:  G L Floersheim
Journal:  Br J Radiol       Date:  1992-11       Impact factor: 3.039

View more
  1 in total

1.  The effect of L-carnitine in the prevention of ionizing radiation-induced cataracts: a rat model.

Authors:  Ibrahim Kocer; Seyithan Taysi; Mustafa Vecdi Ertekin; Ihsan Karslioglu; Akcahan Gepdiremen; Orhan Sezen; Korkmaz Serifoglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-17       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.